OTCMKTS:PCHM PharmChem (PCHM) Stock Price, News & Analysis $3.91 +0.09 (+2.36%) As of 02:27 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartDividendEarningsHeadlinesShort InterestBuy This Stock About PharmChem Stock (OTCMKTS:PCHM) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get PharmChem alerts:Sign Up Key Stats Today's Range$3.82▼$3.9150-Day Range$2.97▼$3.9352-Week Range$2.85▼$3.95Volume1,067 shsAverage Volume1,738 shsMarket Capitalization$18.18 millionP/E Ratio12.22Dividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview PharmChem, Inc. provides PharmChek Sweat Patch that is used to detect drugs of abuse. Its PharmChek Sweat Patch uses sweat as the source and offers alternative to urine testing for cocaine, opiates, amphetamines, PCP, and marijuana. The company was incorporated in 2000 and is based in Fort Worth, Texas. Read More PharmChem Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks9th Percentile Overall ScorePCHM MarketRank™: PharmChem scored higher than 9% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for PharmChem. Earnings and Valuation1.3 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of PharmChem is 12.22, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 25.21.Price to Earnings Ratio vs. SectorThe P/E ratio of PharmChem is 12.22, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 26.17.Read more about PharmChem's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.00% of the float of PharmChem has been sold short.Short Interest Ratio / Days to CoverPharmChem has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous month Dividend0.0 / 5Dividend StrengthN/A Dividend YieldPharmChem does not currently pay a dividend.Dividend GrowthPharmChem does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted0.00% of the float of PharmChem has been sold short.Short Interest Ratio / Days to CoverPharmChem has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous month News and Social Media0.0 / 5News Sentiment0.00 News Coverage This WeekMarketBeat has tracked 2 news articles for PharmChem this week, compared to 0 articles on an average week. Company Ownership0.8 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, PharmChem insiders have not sold or bought any company stock.Percentage Held by Insiders17.40% of the stock of PharmChem is held by insiders. A high percentage of insider ownership can be a sign of company health.Read more about PharmChem's insider trading history. Receive PCHM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for PharmChem and its competitors with MarketBeat's FREE daily newsletter. Email Address PCHM Stock News HeadlinesPharmChem, Inc. (PCHM) - Yahoo FinanceJune 26, 2025 | nz.finance.yahoo.comPharmChem, Inc. (PCHM) stock price, news, quote & history - Yahoo FinanceJune 26, 2025 | au.finance.yahoo.comTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans a chance at true financial independence in the months ahead.” We recently sat down with Rickards to capture all the key details on tape. July 2 at 2:00 AM | Paradigm Press (Ad)PharmChem, Inc. (PCHM) Latest Press Releases & Corporate News - Yahoo FinanceApril 29, 2025 | finance.yahoo.comPharmChem (OTC:PCHM) Stock Quotes, Forecast and News SummaryFebruary 9, 2025 | benzinga.comPharmChem considers strategic alternativesFebruary 3, 2025 | msn.comPharmChem, Inc. Announces Exploration of Strategic AlternativesFebruary 3, 2025 | gurufocus.comPharmChem, Inc. Announces Exploration of Strategic AlternativesFebruary 3, 2025 | prnewswire.comSee More Headlines PCHM Stock Analysis - Frequently Asked Questions How have PCHM shares performed this year? PharmChem's stock was trading at $3.06 at the beginning of the year. Since then, PCHM stock has increased by 27.8% and is now trading at $3.91. View the best growth stocks for 2025 here. How were PharmChem's earnings last quarter? PharmChem Inc. (OTCMKTS:PCHM) announced its earnings results on Friday, May, 9th. The company reported $0.06 earnings per share for the quarter. The company earned $1.58 million during the quarter. How do I buy shares of PharmChem? Shares of PCHM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings5/09/2025Today7/02/2025Next Earnings (Estimated)8/05/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry MED - OUTP/HM CRE Sub-IndustryHealthcare Current SymbolOTCMKTS:PCHM CIKN/A Webwww.pharmchek.com Phone(855) 458-4100Fax817-605-6400Employees170Year FoundedN/AProfitability EPS (Trailing Twelve Months)$0.32 Trailing P/E Ratio12.22 Forward P/E RatioN/A P/E GrowthN/ANet Income$1.38 million Net Margins24.02% Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$6.09 million Price / Sales2.98 Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares4,648,000Free Float3,839,000Market Cap$18.17 million OptionableNot Optionable Beta0.76 7 Stocks to Buy And Hold ForeverEnter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report This page (OTCMKTS:PCHM) was last updated on 7/2/2025 by MarketBeat.com Staff From Our PartnersElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredTrump's ticking time bombA looming tariff deadline on July 9th could be the spark — but what’s buried inside a recent White House docum...Porter & Company | Sponsored“E.I.”- The biggest prediction of my career?One expert predicts that E.I. could see over 200,000% growth... But you need to move fast...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PharmChem Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PharmChem With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.